Patrick LePore

Track

Insider profile

Currently holds positions in Lannett Company Inc and Matinas BioPharma Holdings Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 37% 68% 82%
Transactions
13 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Lannett Company Inc July 1, 2018 -
Independent Vice Chairman of the board Matinas BioPharma Holdings Inc Sept. 5, 2018 -
Independent Director Innoviva Inc Oct. 26, 2016 - Dec. 1, 2018
Independent Director Lannett Company Inc July 1, 2017 - July 1, 2018
Independent Director PharMerica Corp Jan. 14, 2013 - Dec. 7, 2017
Executive Chairman of the Board Par Pharmaceutical Companies Inc (New York) Sept. 28, 2012 - Jan. 31, 2013
Chairman of the Board, Chief Executive Officer Par Pharmaceutical Companies Inc (New York) Nov. 22, 2011 - Sept. 28, 2012
Patrick LePore's trades of Yarrow Bioscience, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
0.49
Quantity 100,000 +20.5%
Value US$49,000
Transaction date
Purchase
Price
0.54
Quantity 50,000 +11.4%
Value US$27,000
Transaction date
Purchase
Price
0.88
Quantity 50,000 +12.9%
Value US$44,000
Transaction date
Purchase
Price
1.71
Quantity 50,000 +14.8%
Value US$85,500
Transaction date
Purchase
Price
4.18
Quantity 20,000 +8.3%
Value US$83,600
Transaction date
Purchase
Price
9.82
Quantity 25,000 +14.2%
Value US$245,500
Transaction date
Purchase
Price
7.32
Quantity 25,000 +21.2%
Value US$183,000
Transaction date
Purchase
Price
8.93
Quantity 25,000 +26.9%
Value US$223,250
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-16 2025-01-15
B Purchase
89,105 +25.0%
309.19
US$4,145,169 		89,105 +25.0% 309.19 US$4,145,169
2023-11-17 2023-11-15
B Purchase
4,302 +1.6%
213.32
US$3,166,110 		4,302 +1.6% 213.32 US$3,166,110
2023-03-22 2023-03-20
B Purchase
48,356 -26.9%
128.20
US$894,845 		48,356 -26.9% 128.20 US$894,845
2022-11-14 2022-11-10
B Purchase
100,000 +20.5%
0.49
US$49,000 		100,000 +20.5% 0.49 US$49,000
2022-05-17 2022-05-16
B Purchase
50,000 +11.4%
0.54
US$27,000 		50,000 +11.4% 0.54 US$27,000
2022-02-10 2022-02-08
B Purchase
50,000 +12.9%
0.88
US$44,000 		50,000 +12.9% 0.88 US$44,000
2021-12-02 2021-11-30
PP Planned purchase
12,500 +25.0%
1.02
US$12,699 		12,500 +25.0% 1.02 US$12,699
2021-11-30 2021-11-29
B Purchase
50,000 +14.8%
1.71
US$85,500 		50,000 +14.8% 1.71 US$85,500
2021-05-12 2021-05-11
B Purchase
20,000 +8.3%
4.18
US$83,600 		20,000 +8.3% 4.18 US$83,600
2021-03-16 2021-03-15
B Purchase
12,500 +100.0%
7.41
US$92,562 		12,500 +100.0% 7.41 US$92,562
2020-12-07 2020-12-03
PP Planned purchase
50,000 +inf%
1.71
US$85,425 		50,000 +inf% 1.71 US$85,425
2020-05-18 2020-05-14
B Purchase
100,000 +33.3%
0.73
US$73,050 		100,000 +33.3% 0.73 US$73,050
2019-09-05 2019-09-03
B Purchase
25,000 +14.2%
9.82
US$245,500 		25,000 +14.2% 9.82 US$245,500
2019-05-20 2019-05-16
B Purchase
100,000 +inf%
0.95
US$95,250 		100,000 +inf% 0.95 US$95,250
2019-05-09 2019-05-08
B Purchase
25,000 +21.2%
7.32
US$183,000 		25,000 +21.2% 7.32 US$183,000
2019-02-13 2019-02-12
B Purchase
25,000 +26.9%
8.93
US$223,250 		25,000 +26.9% 8.93 US$223,250